AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003

por Welm, Alana L
Publicado 2004

mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential

por Faham, Najme, Zhao, Ling, Welm, Alana L.
Publicado 2018

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses

por Eyob, Henok, Ekiz, Huseyin Atakan, Welm, Alana L
Publicado 2013

Toward improved models of human cancer

por Welm, Bryan E., Vaklavas, Christos, Welm, Alana L.
Publicado 2021

The lingering mysteries of metastatic recurrence in breast cancer

por Riggio, Alessandra I., Varley, Katherine E., Welm, Alana L.
Publicado 2020

Short-form Ron is a novel determinant of ovarian cancer initiation and progression

por Moxley, Katherine M., Wang, Luyao, Welm, Alana L., Bieniasz, Magdalena
Publicado 2016

Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4(+) T Cells That Subvert Immunosuppression

por Lai, Shu-Chin Alicia, Gundlapalli, Harika, Ekiz, H. Atakan, Jiang, Amanda, Fernandez, Elvelyn, Welm, Alana L.
Publicado 2021

Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs

por Arnesen, Spencer, Polaski, Jacob T, Blanchard, Zannel, Osborne, Kyle S, Welm, Alana L, O’Connell, Ryan M, Gertz, Jason
Publicado 2023

Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis

por Larrieu-Lahargue, Frédéric, Welm, Alana L., Bouchecareilh, Marion, Alitalo, Kari, Li, Dean Y., Bikfalvi, Andreas, Auguste, Patrick
Publicado 2012

Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth

por Ekiz, Huseyin Atakan, Lai, Shu-Chin Alicia, Gundlapalli, Harika, Haroun, Fadi, Williams, Matthew A., Welm, Alana L.
Publicado 2018

A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis

por Feng, Qiyu, Zhang, Chengliang, Lum, David, Druso, Joseph E., Blank, Bryant, Wilson, Kristin F., Welm, Alana, Antonyak, Marc A., Cerione, Richard A.
Publicado 2017

Breast cancer PDxO cultures for drug discovery and functional precision oncology

por Scherer, Sandra D., Zhao, Ling, Butterfield, Andrew J., Yang, Chieh-Hsiang, Cortes-Sanchez, Emilio, Guillen, Katrin P., Welm, Bryan E., Welm, Alana L.
Publicado 2023

The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming

por Cunha, Stéphanie, Lin, Yi-Chun, Goossen, Elizabeth A., DeVette, Christa I., Albertella, Mark R., Thomson, Stuart, Mulvihill, Mark J., Welm, Alana L.
Publicado 2014

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion

por Olson, Michael L., Mause, Erica R. Vander, Radhakrishnan, Sabarinath V., Brody, Joshua D., Rapoport, Aaron P., Welm, Alana L., Atanackovic, Djordje, Luetkens, Tim
Publicado 2022

Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts

por Petrosyan, Varduhi, Dobrolecki, Lacey E., LaPlante, Emily L., Srinivasan, Ramakrishnan Rajaram, Bailey, Matthew H., Welm, Alana L., Welm, Bryan E., Lewis, Michael T., Milosavljevic, Aleksandar
Publicado 2022

Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma

por Chaturvedi, Aashi, Hoffman, Laura M., Jensen, Christopher C., Lin, Yi-Chun, Grossmann, Allie H., Randall, R. Lor, Lessnick, Stephen L., Welm, Alana L., Beckerle, Mary C.
Publicado 2014

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

por Palomeras, Sònia, Diaz-Lagares, Ángel, Viñas, Gemma, Setien, Fernando, Ferreira, Humberto J., Oliveras, Glòria, Crujeiras, Ana B., Hernández, Alejandro, Lum, David H., Welm, Alana L., Esteller, Manel, Puig, Teresa
Publicado 2019

A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer

por DeVette, Christa I., Gundlapalli, Harika, Lai, Shu-Chin Alicia, McMurtrey, Curtis P., Hoover, Ashley R., Gurung, Hem R., Chen, Wei R., Welm, Alana L., Hildebrand, William H.
Publicado 2019

Plasma exosome microRNAs are indicative of breast cancer

por Hannafon, Bethany N., Trigoso, Yvonne D., Calloway, Cameron L., Zhao, Y. Daniel, Lum, David H., Welm, Alana L., Zhao, Zhizhuang J., Blick, Kenneth E., Dooley, William C., Ding, W. Q.
Publicado 2016

An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer

por Scherer, Sandra D., Riggio, Alessandra I., Haroun, Fadi, DeRose, Yoko S., Ekiz, H. Atakan, Fujita, Maihi, Toner, Jennifer, Zhao, Ling, Li, Zheqi, Oesterreich, Steffi, Samatar, Ahmed A., Welm, Alana L.
Publicado 2021